Screener
XPH vs KCE
State Street SPDR S&P Pharmaceuticals ETF vs State Street SPDR S&P Capital Markets ETF
Key differences
- Over the last 3 years, KCE has delivered higher annualized returns.
Side-by-side comparison
| XPH | KCE | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $355M | $456M |
| Since | 2006 | 2005 |
| Dividend yield | 0.65% | 1.70% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +46.3% | +15.1% |
| CAGR 3Y | +13.8% | +26.5% |
| CAGR 5Y | +4.5% | +12.9% |
| Sharpe 3Y | 0.57 | 1.05 |
| Volatility 1Y | 21.29% | 19.67% |
| Max drawdown | -35.96% | -40.78% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XPH and KCE
Explore further